• Acne
  • Actinic Keratosis
  • Aesthetics
  • Alopecia
  • Atopic Dermatitis
  • Buy-and-Bill
  • COVID-19
  • Case-Based Roundtable
  • Chronic Hand Eczema
  • Chronic Spontaneous Urticaria
  • Drug Watch
  • Eczema
  • General Dermatology
  • Hidradenitis Suppurativa
  • Melasma
  • NP and PA
  • Pediatric Dermatology
  • Pigmentary Disorders
  • Practice Management
  • Precision Medicine and Biologics
  • Prurigo Nodularis
  • Psoriasis
  • Psoriatic Arthritis
  • Rare Disease
  • Rosacea
  • Skin Cancer
  • Vitiligo
  • Wound Care

Article

Medicare reform law carries hidden costs

Author(s):

Bob Gatty

While Medicare recipients now have some help in covering the cost of prescription drugs, the new Medicare reform law passed by Congress carries some hidden costs that may result in difficulties in obtaining care for some patients. This applies, in particular, to physicians who administer drugs in their offices.

Newsletter

Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.

Subscribe Now!
Related Videos
Expanding Topical Non-Steroidal Options in Atopic Dermatitis to Reduce Chronic Steroid Use
Expanding Topical Non-Steroidal Options in Atopic Dermatitis to Reduce Chronic Steroid Use
Understanding the Role of OX40 in Next-Generation Eczema Therapies
Understanding the Role of OX40 in Next-Generation Eczema Therapies
Jonathan Silverberg, MD, PhD, MPH on Keeping Up With Rapid AD Developments
Jonathan Silverberg, MD, PhD, MPH on Keeping Up With Rapid AD Developments
The Vicious Cycle of Itch, Stress, and Sleep Loss
The Vicious Cycle of Itch, Stress, and Sleep Loss
Christopher Bunick, MD, PhD, Previews RAD 2025: Raising the Bar in Atopic Dermatitis Care
Christopher Bunick, MD, PhD, Previews RAD 2025: Raising the Bar in Atopic Dermatitis Care
1 expert in this video
Current Unmet Needs and Emerging Solutions in Atopic Dermatitis Management
1 expert in this video
Implementation Factors Affecting Ruxolitinib Adoption in Pediatric Dermatology Practice
1 expert in this video
Regulatory Challenges and Clinical Differentiators for Pediatric Atopic Dermatitis Treatments
1 expert in this video
Evaluating the Impact of Topical JAK Inhibitors on Pediatric Atopic Dermatitis Guidelines
1 expert in this video
The Future of Pediatric Atopic Dermatitis Treatment and Emerging Therapies
Related Content
Exploring Varying Doses of Oral Isotretinoin for Facial Warts and its Impact on Quality of Life
May 1st 2025

Exploring Varying Doses of Oral Isotretinoin for Facial Warts and its Impact on Quality of Life

Derm Dispatch: A Comprehensive Guide to Managing Eczema with Integrative Medicine
March 31st 2025

Derm Dispatch: A Comprehensive Guide to Managing Eczema with Integrative Medicine

Dermatology Conferences and Meetings Calendar: May 2025
May 1st 2025

Dermatology Conferences and Meetings Calendar: May 2025

The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients
August 2nd 2024

The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients

Optimizing Atopic Dermatitis Care With Emerging Topical Therapeutics
April 30th 2025

Optimizing Atopic Dermatitis Care With Emerging Topical Therapeutics

Q32 Bio’s Bempikibart Receives FDA Fast Track Designation for Alopecia Areata
April 30th 2025

Q32 Bio’s Bempikibart Receives FDA Fast Track Designation for Alopecia Areata

© 2025 MJH Life Sciences

All rights reserved.